Cookie Policy

By clicking "Accept", you are agreeing to continue browsing and accept the website privacy policy.

Responsive image

Drug Information

Drug Generic Name CHLOROQUINE
Drug Class DRUGS SUPPRESSIG THE RHEUMATIC DISEASE PROCESS
Chapter Musculoskeletal and Joint Diseases

Indications: active rheumatoid arthritis, systemic lupus erythematosus; malaria.

Cautions: renal and hepatic impairment, pregnancy, porphyria, psoriasis, glucose-6-phosphate dehydorgenase deficiency; elderly patients, children; regular ophthalmic examinations required.

Contra-indications: pre-existing maculoretinopathy; concurrent therapy with hepatotoxic drugs.

Side Effects: gastro-intestinal disturbances, headache, visual disturbances, irreversible retinal damage, corneal opacities, depigmentation or loss of hair, skin reactions that could be severe to mandate discontinuation of treatment; can rarely lead to deafness; neuromyopathy, sensitization and blood disorders such as thrombocytopenia.

Dose: administered on expert advice, chloroquine (base) 150mg daily after food.

Max. 2.5mg/kg daily. Child, 3mg/kg daily.

Note: 200mg of chloroquine sulfate

= 250mg chloroquine phosphate

= 150mg chloroquine.

Brand Name
  • Nivaquine tablets 200mg
rating - 1 starrating - 2 starrating - 3 starrating - 4 starrating - 5 star